Merck kicks off oral COVID-19 antiviral filing in Canada

Merck kicks off oral COVID-19 antiviral filing in Canada

Submitted by admin on August 16, 2021 - 11:04am
Source: 
Pharmaforum
News Tags: 
Merck
COVID-19
antivirals
Canada
Health Canada
molnupiravir
Headline: 
Merck kicks off oral COVID-19 antiviral filing in Canada
snippet: 

Health Canada has started a rolling review of Merck & Co’s molnupiravir, an oral antiviral therapy treatment for COVID-19 partnered with Ridgeback Biotherapeutics.

Do Not Allow Advertisers to Use My Personal information